DISHMAN

Janmejay R Vyas has submitted to the Exchange, vide letter dated August 05, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Janmejay R. Vyas has submitted to the Exchange, vide letter dated April 03, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Janmejay R. Vyas has submitted to the Exchange, vide letter dated March 13, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Janmejay R. Vyas has submitted to the Exchange, vide letter dated March 05, 2013 a copy of Disclosure in terms of Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Janmejay R. Vyas has submitted to the Exchange, vide letter dated March 04, 2013 a copy of Disclosure in terms of Regulation 31(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Janmejay R. Vyas has submitted to the Exchange, vide letter dated March 02, 2013 a copy of Disclosure in terms of Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Janmejay R. Vyas has submitted to the Exchange, vide letter dated Februay 28, 2013 a copy of Disclosure in terms of Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Janmejay R. Vyas has submitted to the Exchange, vide letter dated Februay 27, 2013 a copy of Disclosure in terms of Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Janmejay R. Vyas has submitted to the Exchange, vide letter dated Februay 19, 2013 a copy of Disclosure in terms of Regulation 31(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Janmejay R. Vyas has submitted to the Exchange vide letter dated Februay 11, 2013 a copy of Disclosure in terms of Regulation 31(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Janmejay R Vyas has submitted to the Exchange vide letter dated January 25, 2013 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Janmejay R. Vyas has submitted to the Exchange vide letter dated December 31, 2012, a copy of Disclosure under Regulation 31(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Janmejay R. Vyas has submitted to the Exchange vide letter dated December 05, 2012, a copy of Disclosure of release of encumbered shares as required under Regulation 31(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Janmejay R. Vyas has submitted to the Exchange vide letter dated September 05, 2012, a copy of Disclosure of release of encumbered shares as required under Regulation 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Janmejay R. Vyas has submitted to the Exchange vide letter dated May 16, 2012, a copy of Disclosure in terms of Regulation 31(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Mr Janmejay R Vyas has submitted to the Exchange vide letter dated March 30 2012, a copy of Disclosure in terms of Regulation 31(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dishman Pharmaceuticals And Chemicals Limited has submitted to the Exchange the Disclosures under Regulation 7(3) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997.

Dishman Pharmaceuticals And Chemicals Limited has submitted to the Exchange a copy of Disclosure under Regulation 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Dishman Pharmaceuticals And Chemicals Limited has informed the Exchange regarding the change in shareholding in respect of persons holding more than 5% shares of Dishman Pharmaceuticals Limited as follows : 1)HDFC Trustee Company Limited A/c HDFC Equity Fund holds 17,04,975 shares(2.48%) and HDFC Trustee Company Limited A/c HDFC Prudence Fund holds NIL shares. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

HDFC Asset Management Company Limited has informed the Exchange that with respect to the aggregate holding of the Schemes of HDFC Mutual Fund in Dishman Pharmaceuticals Limited("the Company"), there has been a decrease in the shareholding of the Company by the Schemes of HDFC Mutual Fund by 2.58% as of March 28,2006. As on March 28, 2006, the aggregate holding of the Schemes of HDFC Mutual Fund in the company is 2.48% of the paid up equity share capital of the Company. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcemen

Dishman Pharmaceuticals And Chemicals Limited has informed the Exchange that Bhadra-Raj Holdings Pvt. Ltd(promoter group company) has sold 10,09,850 shares of Dishman Pharmaceuticals And Chemicals Limited on February 01, 2006. The mode of sale is Market Sale and the shareholding of Bhadra-Raj Holdings Pvt. Ltd after the said sale is 6,00,000 shares aggregating to 0.87% of the share capital of Dishman Pharmaceuticals And Chemicals Limited.

Dishman Pharmaceuticals And Chemicals Limited has informed the Exchange that Mr. Rajnikant T. Vyas, Director of the Company has sold 15,00,000 shares of Dishman Pharmaceuticals And Chemicals Limited on January 31, 2006. The mode of sale is Market Sale and the shareholding of Mr. Rajnikant T. Vyas after the said sale is 12323300 shares aggregating to 17.95% of the share capital of Dishman Pharmaceuticals And Chemicals Limited.

Dishman Pharmaceuticals And Chemicals Limited has informed the Exchange that HDFC Mutual Fund: HDFC Prudence Fund, has acquired 25,000 shares aggregating to 0.18% of the total paid up capital of Dishman Pharmaceuticals and Chemicals Limited on June 09, 2005. The mode of acquisition is Market Purchase and the details of shareholding of HDFC Mutual Fund after the said acquisition is as follows: (i) HDFC Mutual Fund, Scheme - HDFC Prudence Fund holds 245,000 equity shares aggregating to 1.78% of the paid up share capital of Dishman Pharmaceuticals and Chemicals Limited; (ii) HDFC Mutual Fund: HDF

HDFC Asset Management Company Limited has informed the Exchange that HDFC Mutual Fund under its Scheme HDFC Prudence Fund, has acquired 25,000 shares aggregating to 0.18% of the total paid up capital of Dishman Pharmaceuticals and Chemicals Limited on June 09, 2005. The mode of acquisition is Market Purchase and the details of shareholding after the said acquisition is as follows: (i) HDFC Mutual Fund, Scheme - HDFC Prudence Fund holds 245,000 equity shares aggregating to 1.78% of the paid up share capital of Dishman Pharmaceuticals and Chemicals Limited; (ii) HDFC Mutual Fund, Scheme - HDFC E

Dishman Pharmaceuticals And Chemicals Limited has informed the Exchange of the details of the acquisition/sale as follows: 1) Sanjay S Majmudar, Director of the Company has acquired 4280 shares on May 30, 2005 through Off Market Purchase and his shareholding after the said acquisition is 4330 shares aggregating to 0.032% of the share capital of Dishman Pharmaceuticals and Chemicals Limited; 2) Ratna S Majmudar, Wife of Mr. Sanjay S Majmudar has acquired 2470 shares on May 31, 2005 through Off Market Purchase and her shareholding after the said acquisition is 2470 shares aggregating to 0.0180%